Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Di Giacomo

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Seminars in Oncology|May 13, 2015
Immunologic checkpoints for cancer treatment: a continuing successMichele Maio, Anna Maria Di Giacomo
Seminars in Oncology|May 13, 2015
Immune checkpoint blockade in patients with melanoma metastatic to the brainAnna Maria Di Giacomo, Kim Margolin
The Lancet. Oncology|February 3, 2022
Nivolumab plus ipilimumab in melanoma brain metastasesAnna Maria Di Giacomo, Michele Maio
Seminars in Oncology|November 16, 2010
The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indicationsAnna Maria Di Giacomo, Maurizio Biagioli, Michele Maio
Journal of Neuro-Oncology|August 29, 2016
Long-term follow-up of a papillary tumor of the pineal region: addendum to a case reportLaura Lippa, Anna Maria Di Giacomo, Alfonso Cerase
Journal of Translational Medicine|June 29, 2004
Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?Ester Fonsatti, Anna Maria Di Giacomo, Michele Maio
Seminars in Oncology|November 16, 2010
Brain metastasis in melanoma: clinical activity of CTLA-4 antibody therapyKim A Margolin, Anna Maria Di Giacomo, Michele Maio
Seminars in Oncology|May 13, 2015
Immunologic correlates in the course of treatment with immunomodulating antibodiesBenjamin Weide, Anna Maria Di Giacomo, Ester Fonsatti, et al.
Annals of the New York Academy of Sciences|October 12, 2012
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyondRiccardo Danielli, Ester Fonsatti, Luana Calabrò, et al.
Cytokine & Growth Factor Reviews|July 25, 2017
Immunotherapy targeting immune check-point(s) in brain metastasesAnna Maria Di Giacomo, Monica Valente, Alessia Covre, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|May 13, 2015
Immunologic checkpoints for cancer treatment: a continuing successMichele Maio, Anna Maria Di Giacomo
Seminars in Oncology|May 13, 2015
Immune checkpoint blockade in patients with melanoma metastatic to the brainAnna Maria Di Giacomo, Kim Margolin
The Lancet. Oncology|February 3, 2022
Nivolumab plus ipilimumab in melanoma brain metastasesAnna Maria Di Giacomo, Michele Maio
Seminars in Oncology|November 16, 2010
The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indicationsAnna Maria Di Giacomo, Maurizio Biagioli, Michele Maio
Journal of Neuro-Oncology|August 29, 2016
Long-term follow-up of a papillary tumor of the pineal region: addendum to a case reportLaura Lippa, Anna Maria Di Giacomo, Alfonso Cerase
Journal of Translational Medicine|June 29, 2004
Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?Ester Fonsatti, Anna Maria Di Giacomo, Michele Maio
Seminars in Oncology|November 16, 2010
Brain metastasis in melanoma: clinical activity of CTLA-4 antibody therapyKim A Margolin, Anna Maria Di Giacomo, Michele Maio
Seminars in Oncology|May 13, 2015
Immunologic correlates in the course of treatment with immunomodulating antibodiesBenjamin Weide, Anna Maria Di Giacomo, Ester Fonsatti, et al.
Annals of the New York Academy of Sciences|October 12, 2012
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyondRiccardo Danielli, Ester Fonsatti, Luana Calabrò, et al.
Cytokine & Growth Factor Reviews|July 25, 2017
Immunotherapy targeting immune check-point(s) in brain metastasesAnna Maria Di Giacomo, Monica Valente, Alessia Covre, et al.
Pageof 13